141 filings
Page 3 of 8
6-K
OPT
Opthea Limited
24 Jul 23
Current report (foreign)
6:01am
6-K
OPT
Opthea Limited
13 Jul 23
Current report (foreign)
6:02am
6-K
OPT
Opthea Limited
10 Jul 23
Opthea Announces Departure of Chief Medical Officer and Appointment of Senior Medical Advisor
6:04am
6-K
OPT
Opthea Limited
8 Jun 23
Opthea Appoints Anshul Thakral as Non-Executive Director of the Board
6:02am
6-K
OPT
Opthea Limited
25 May 23
Opthea to Present at the Jefferies 2023 Healthcare Conference
6:02am
6-K
OPT
Opthea Limited
17 May 23
Current report (foreign)
6:01am
6-K
OPT
Opthea Limited
8 May 23
Opthea To Present at the JMP Securities Life Sciences Conference
6:02am
6-K
OPT
Opthea Limited
28 Apr 23
Opthea To Participate at the H.C. Wainwright BioConnect Conference at NASDAQ
8:46am
6-K
OPT
Opthea Limited
7 Mar 23
Current report (foreign)
6:01am
6-K
OPT
Opthea Limited
6 Mar 23
Opthea To Participate in Fireside Chat at Oppenheimer’s 33rd Annual Healthcare Conference
6:02am
6-K
OPT
Opthea Limited
23 Feb 23
Current report (foreign)
6:03am
SC 13G/A
OPT
Opthea Limited
15 Feb 23
Opthea / Regal Partners ownership change
6:01am
SC 13G/A
OPT
Opthea Limited
14 Feb 23
Opthea / BAKER BROS. ADVISORS ownership change
4:00pm
6-K
OPT
Opthea Limited
13 Feb 23
Opthea Phase 2b Trial Results of OPT-302 in Combination with Lucentis® for wet AMD Published in the Journal Ophthalmology
6:03am
6-K
OPT
Opthea Limited
6 Feb 23
Opthea To Present at SVB Leerink Global Biopharma Conference
6:02am
6-K
OPT
Opthea Limited
30 Jan 23
Opthea To Present at Sequire Biotechnology Conference
6:02am
6-K
OPT
Opthea Limited
11 Jan 23
Current report (foreign)
6:02am
6-K
OPT
Opthea Limited
12 Dec 22
Opthea Announce MST Access Hosted Conference Call with Professor Jason S. Slakter, MD
6:04am
6-K
OPT
Opthea Limited
6 Dec 22
Current report (foreign)
6:02am
6-K
OPT
Opthea Limited
16 Nov 22
Current report (foreign)
4:18pm